Monossacáridos

<p>Methyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside is a benzylated glycoside that inhibits the activity of β-glucosidases and glycoside hydrolases. It is used as an inhibitor in ecological studies to investigate the effects of benzyl groups on biotic and abiotic stressors. Methyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside has been shown to have inhibitory potency against the transition state in enzymatic reactions. This compound also has been shown to be effective in treating diabetes.</p>

<p>D-Glucosamine-2-N, 3-O, 6-O-trisulfate sodium salt is a high purity oligosaccharide that can be custom synthesized. This product is composed of sugar, Click modification, fluorination, glycosylation, and methylation. It has CAS No. and Oligosaccharide. This product is used in the production of complex carbohydrates due to its saccharide composition.</p>

<p>A toxic glucosamine derivative, widely used for the induction of diabetes in experimental animals. The compound enters the pancreatic β cells in Langerhans islets via glucose transporter GLUT2. It has the ability to alkylate DNA and trigger the production of ROS and nitric oxide, which contribute to DNA and mitochondrial damage. Moreover, streptozocin inhibits N-acetyl-β-D-glucosaminidase and disrupts O-GlcNAc cycling. This molecule has also been used as antimicrobial compound and chemotherapeutic agent for some types of pancreatic cancer.</p>

<p>2,3,5-Tri-O-benzoyl-2-C-methyl-D-ribonic acid-1,4-lactone is a glutamate receptor agonist that has been shown to have pharmacological properties. It binds to the GluR2/3 family of glutamate receptors and is an agonist at these receptors. The experiments with this drug have been conducted on both animals and humans. 2,3,5-Tri-O-benzoyl-2-C-methyl D ribonic acid lactone has also been shown to be an effective probe for the identification of glutamate receptor sequences in the brain and spinal cord.</p>

<p>Methyl 7-chloro-7-deoxy-1-thiolincosaminide is a modification of the monosaccharide D-glucose. It has a CAS number of 22965-79-3 and is a white powder. Methyl 7-chloro-7-deoxy-1-thiolincosaminide can be used in the production of various carbohydrates, such as oligosaccharides and polysaccharides. This compound is also useful for the synthesis of sugar related products, including saccharides, glycosylation, and fluorination. Methyl 7-chloro-7-deoxy 1 -thiolincosaminide has been shown to be highly pure and synthetic, making it suitable for use in research or industrial settings.</p>

<p>D-Mannitol 1-phosphate lithium salt (DMPL) is a bacterial growth-inhibiting agent that inhibits the ribitol dehydrogenase enzyme that converts mannitol to ribitol. The wild-type strain of bacteria is more sensitive to DMPL than the mutant strains, which lack this enzyme. This compound has been shown to be active against Aerobacter aerogenes, and it can be used as an antimicrobial agent in plant physiology, where it prevents cell lysis. DMPL is also effective against wild-type strains of E. coli K-12 and has a broad range of pH optima with a maximum at pH 6.0 to 7.0. The reaction mechanism for this drug is not well understood, but it may involve inhibition of the polymerase chain reaction or other enzyme activities.</p>

<p>Salicylic acid-acyl-b-D-glucuronide is an anti-inflammatory compound that is found in the urine of diabetic patients. It has been shown to inhibit the production of a number of proinflammatory compounds, including prostaglandin E2 (PGE2), in human serum. Salicylic acid-acyl-b-D-glucuronide is formed by the reaction of salicylic acid with acetylsalicylic acid. The rate of formation is dependent on the concentration of salicylic acid and pH. The reactive product can form covalent adducts with tyrosinase and other proteins, leading to inhibition of tyrosinase activity and melanin synthesis.</p>

<p>2,3:4,6-Di-O-isopropylidene-2-keto-L-gulonic acid sodium salt is a fatty acid that has been used as an antipsychotic drug. It is the active metabolite of clozapine and has been shown to have similar efficacy to other first generation antipsychotics such as chlorpromazine and haloperidol. 2,3:4,6-Di-O-isopropylidene-2-keto-L-gulonic acid sodium salt also has a low energy content and can be audited for its locomotor activity. This drug is a metabolic product of clozapine and has been shown to have similar efficacy to other first generation antipsychotics such as chlorpromazine and haloperidol. 2,3:4,6-Di-O-isopropylidene-2-keto--L--gulonic acid</p>

<p>2,3-O-Isopropylidene-D-apiose is a high purity product that can be custom synthesized. It is a sugar that can be modified with fluorination, glycosylation, and methylation. 2,3-O-Isopropylidene-D-apiose has been shown to be an effective synthetic carbohydrate and can be used as a drug delivery system. This product is soluble in methanol and water and has the CAS number 94943-41-6.</p>

<p>Synthetic building block</p>

<p>Synthetic carbohydrate building block</p>

<p>2-Acetamido-2-deoxy-D-glucopyranose 6-sulphate sodium salt is an Oligosaccharide which is a carbohydrate. It has a CAS No. 108321-79-5 and is available for custom synthesis. 2-Acetamido-2-deoxy-D-glucopyranose 6 sulphate sodium salt can be modified with methylation, saccharide, polysaccharide, click modification, or modification. It can also be glycosylated and fluorinated. The chemical formula of this compound is C6H11NO4SNaO6</p>

<p>E-Retinyl b-glucuronide is a metabolite of vitamin A that is formed in the liver by glucuronidation of retinol. It has been shown to have immunomodulatory effects and can be used to activate various immune cells, such as T lymphocytes, monocytes, and natural killer cells. E-Retinyl b-glucuronide binds to cell surface antigens and induces the expression of surface markers on mononuclear cells. In vitro studies have shown that this metabolite has growth-promoting activity for certain types of cancerous cells including colon carcinoma, breast carcinoma, and thyroid carcinoma. E-Retinyl b-glucuronide is also known to inhibit the binding of 13-cis retinoic acid to its receptor, thereby preventing the activation of genes in target tissues.</p>

<p>Voglibose is a competitive inhibitor of α-glucosidase used for the control of blood sugar levels in patients with type 2 diabetes mellitus. The compound binds reversibly to intestinal carbohydrate-active digestive enzymes with α-glucosidase activity, inhibits breakdown of complex sugars and consequently delays the absorption of glucose into blood.</p>

<p>Phenyl a-D-galactopyranoside is a pesticide that is used to control the growth of endophytic fungi. It has been shown to have an antibacterial effect against Gram-positive bacteria and can be used as a fungicide. Phenyl a-D-galactopyranoside can be synthesized from the corresponding synthons, which are 3-hydroxybenzoic acid and 4-methylphenol. This compound contains a carbonyl group and hydroxyl group that are reactive with enzymes such as esterases, glucuronidases, and glutathione reductase, which hydrolyzes it into its inactive form.</p>

<p>Quercetin-3-O-b-D-glucose-7-O-b-D-gentiobioside is a flavonoid that is found in fruits and vegetables. Quercetin has been shown to have antioxidative activity and can be used as a dietary supplement for the prevention of cardiovascular disease. Quercetin has also been shown to inhibit the oxidation of cholesterol, which may help prevent atherosclerosis. Quercetin has been shown to have antiinflammatory properties in women with symptoms of premenstrual syndrome (PMS). Quercetin inhibits the production of prostaglandins, which are inflammatory mediators that are associated with PMS. Quercetin also blocks the inflammatory effects of methyl linoleate, a fatty acid found in meat, dairy products, and vegetable oils. Quercetin has also been shown to bind with specific proteins on white blood cells called immunoglobulins or antibodies. The</p>

<p>Glucose analog and potent inhibitor of α-glucosidases of class I and II. It interferes with N-linked glycosylation and oligosaccharide processing. The compound inhibits intestinal α-glucosidase and has protective effects against obesity-induced hepatic injury as well as mitochondrial dysfunction. It also has neuroprotective effects since it reduces senescence-related cognitive impairment, neuroinflammation and amyloid beta deposition in mice.</p>

<p>2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranosyl-Fmoc-asparagine is a synthetic oligosaccharide that has been modified with a fluorine atom at the 6 position. The acetamido group has been methylated and the sugar moiety is attached to an Fmoc group. The molecular weight of this compound is 1,000. It can be used for the synthesis of saccharides and polysaccharides by click chemistry or as a monosaccharide in carbohydrate research. 2AATGFFmocAsp can also be used for modification purposes with different reagents such as hydrazine, NIS, and TEMPO.</p>

<p>1,2,6-Tri-O-acetyl-3,4-di-O-benzyl-a-D-mannopyranose is a synthetic sugar that has been modified with three acetates and benzyl groups. It is used in the synthesis of glycosides and oligosaccharides. 1,2,6-Tri-O-acetyl-3,4-di-O-benzyl-a-D-mannopyranose is also an important building block for the synthesis of complex carbohydrates.</p>

<p>Methyl 4,6-O-benzylidene-b-D-galactopyranoside is a sugar that has a molecular formula of C14H18O7. This compound crystallizes in the monoclinic system with unit cell dimensions of a=11.74 Å, b=8.92 Å, c=5.81 Å and β=106.39°. The methyl 4,6-O-benzylidene group is attached to the galactose ring via an ether bond at C4' and C6'. Methyl 4,6-O-benzylidene-b-D-galactopyranoside has been shown to possess receptor binding properties by inhibiting acetylcholine release when it binds to the acetylcholine receptors on the surface of muscle cells. Methyl 4,6-O-benzylidene-b-D-galactopyr</p>